|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran.
|
31372169 |
2019 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Preoperative blood tests, magnetic resonance imaging, and an endocrine tolerance test indicated that the patient's symptoms satisfied the diagnostic criteria for acromegaly, with a suspected diagnosis of an RCC and growth hormone (GH)-producing PA. Endoscopic transsphenoidal surgery (eTSS) was performed.
|
30862574 |
2019 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin-like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity.
|
30843342 |
2019 |
|
Pituitary Adenoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Attenuation of EGFL7 Expression Inhibits Growth Hormone-Producing Pituitary Adenomas Growth and Invasion.
|
29466872 |
2018 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas.
|
29155347 |
2018 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We identified 25 patients aged 20 years or younger with GH-producing PAs who underwent surgery between 2003 and 2016 at Toranomon Hospital in Tokyo.
|
28849339 |
2018 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
|
29906579 |
2018 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
|
29902603 |
2018 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas.
|
28602880 |
2017 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone-Secreting Pituitary Adenomas-Systematic Review and Meta-Analysis.
|
27756664 |
2017 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Management of aggressive growth hormone secreting pituitary adenomas.
|
27987061 |
2017 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
|
28705113 |
2017 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
PD-L1 RNA and protein expression were significantly increased in functioning (growth hormone and prolactin-expressing) pituitary adenomas compared to non-functioning (null cell and silent gonadotroph) adenomas.
|
27655724 |
2016 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Role of mTOR Inhibitors in Growth Hormone-Producing Pituitary Adenomas Harboring Different FGFR4 Genotypes.
|
27267848 |
2016 |
|
Pituitary Adenoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Pituitary adenomas expressing and secreting GH are invariably benign and exhibit DNA damage and a senescent phenotype.
|
23940366 |
2013 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Thus, germline AIP or MEN1 gene mutations are frequent among pediatric patients with GH- or PRL-secreting PA but are significantly rarer in pediatric CD; PRKAR1A mutations are not present in PA outside of Carney complex.
|
20507346 |
2010 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Improvement of congestive heart failure after octreotide and transsphenoidal surgery in a patient with acromegaly.
|
19420816 |
2009 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
To date, mutations at the codon encoding R201, typically underlying the McCune-Albright syndrome and isolated fibrous dysplasia of bone, have been demonstrated only in growth hormone secreting pituitary adenomas.
|
11836449 |
2002 |
|
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Pituitary adenoma producing growth hormone and adrenocorticotropin: a histological, immunocytochemical, electron microscopic, and in situ hybridization study. Case report.
|
9609310 |
1998 |